The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
hsa_circ_0013958: a circular RNA and potential novel biomarker for lung adenocarcinoma
Open accessAbstract
Circular RNA s (circ RNA s) are associated with cancer progression and metastasis, although little is known about their role in lung adenocarcinoma (LAC). In the present study, microarrays were first used to screen for tumour‐specific circ RNA candidates in LAC tissue. Thirty‐nine circ RNA s were found to be up‐regulated and 20 were down‐regulated (fold change > 2.0). Among them, hsa_circ_0013958 was further confirmed to be up‐regulated in all of the LAC tissues, cells and plasma. In addition, hsa_circ_0013958 levels were associated with TNM stage (P = 0.009) and lymphatic metastasis (P = 0.006). The area under the receiver operating characteristic curve was 0.815 (95% confidence interval = 0.727–0.903; P < 0.001). In addition, to further illustrate the bioactivities of hsa_circ_0013958 in LAC, si RNA‐mediated inhibition of hsa_circ_0013958 was performed in vitro. The results showed that hsa_circ_0013958 promoted cell proliferation and invasion and inhibited cell apoptosis in LAC. Moreover, hsa_circ_0013958 was identified as a sponge of miR‐134, and thus it up‐regulated oncogenic cyclin D1, which plays a pivotal role in the development of non‐small cell lung cancer. In conclusion, our results suggested that hsa_circ_0013958 could be used as a potential non‐invasive biomarker for the early detection and screening of LAC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Natural RNA circles function as efficient microRNA sponges
Hansen, T. B., Jensen, T. I., Clausen, B. H., Bramsen, J. B., Finsen, B., Damgaard, C. K., & Kjems, J. (2013) · Nature · doi:10.1038/nature11993 · Cited by 7,985
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Li, J.-H., Liu, S., Zhou, H., Qu, L.-H., & Yang, J.-H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1248 · Cited by 4,686
Zheng, Q., Bao, C., Guo, W., Li, S., Chen, J., Chen, B., Luo, Y., Lyu, D., Li, Y., Shi, G., et al. (2016) · Nature Communications · doi:10.1038/ncomms11215 · Cited by 2,043
circBase: a database for circular RNAs
Glažar, P., Papavasileiou, P., & Rajewsky, N. (2014) · RNA · doi:10.1261/rna.043687.113 · Cited by 1,933
Circular RNA: a new star of noncoding RNAs
Qu, S., Yang, X., Li, X., Wang, J., Gao, Y., Shang, R., Sun, W., Dou, K., & Li, H. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.06.003 · Cited by 1,808
Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Mis-splicing yields circular RNA molecules.
Cocquerelle, C., Mascrez, B., Hétuin, D., & Bailleul, B. (1993) · The FASEB Journal · doi:10.1096/fasebj.7.1.7678559 · Cited by 1,197
Using circular RNA as a novel type of biomarker in the screening of gastric cancer
Li, P., Chen, S., Chen, H., Mo, X., Li, T., Shao, Y., Xiao, B., & Guo, J. (2015) · Clinica Chimica Acta · doi:10.1016/j.cca.2015.02.018 · Cited by 774
Circular RNAs are miRNA sponges and can be used as a new class of biomarker
Kulcheski, F. R., Christoff, A. P., & Margis, R. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.09.011 · Cited by 740
Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram‐Baptiste, D., Saslow, D., Brawley, O. W., & Wender, R. C. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21392 · Cited by 719
Sumazin, P., Yang, X., Chiu, H.-S., Chung, W.-J., Iyer, A., Llobet-Navas, D., Rajbhandari, P., Bansal, M., Guarnieri, P., Silva, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.09.041 · Cited by 697
Non–Small Cell Lung Cancer, Version 6.2015
Ettinger, D. S., Wood, D. E., Akerley, W., Bazhenova, L. A., Borghaei, H., Camidge, D. R., Cheney, R. T., Chirieac, L. R., D’Amico, T. A., Demmy, T. L., et al. (2015) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2015.0071 · Cited by 478
Smith, R. A., Manassaram‐Baptiste, D., Brooks, D., Doroshenk, M., Fedewa, S., Saslow, D., Brawley, O. W., & Wender, R. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21261 · Cited by 451
Hsa_circ_0001649: A circular RNA and potential novel biomarker for hepatocellular carcinoma
Qin, M., Liu, G., Huo, X., Tao, X., Sun, X., Ge, Z., Yang, J., Fan, J., Liu, L., & Qin, W. (2016) · Cancer Biomarkers · doi:10.3233/cbm-150552 · Cited by 441
Circular RNA participates in the carcinogenesis and the malignant behavior of cancer
Zhao, Z.-J., & Shen, J. (2017) · RNA Biology · doi:10.1080/15476286.2015.1122162 · Cited by 425
Circular RNA-ITCH Suppresses Lung Cancer Proliferation via Inhibiting the Wnt/β-Catenin Pathway
Wan, L., Zhang, L., Fan, K., Cheng, Z.-X., Sun, Q.-C., & Wang, J.-J. (2016) · BioMed Research International · doi:10.1155/2016/1579490 · Cited by 341
Circular RNAs: a new frontier in the study of human diseases
Chen, Y., Li, C., Tan, C., & Liu, X. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103758 · Cited by 293
Self-citationXia, W., Qiu, M., Chen, R., Wang, S., Leng, X., Wang, J., Xu, Y., Hu, J., Dong, G., Xu, P. L., et al. (2016) · Scientific Reports · doi:10.1038/srep35576 · Cited by 270
Kitamura, K., Seike, M., Okano, T., Matsuda, K., Miyanaga, A., Mizutani, H., Noro, R., Minegishi, Y., Kubota, K., & Gemma, A. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0448 · Cited by 187
Li, J., Wang, Y., Luo, J., Fu, Z., Ying, J., Yu, Y., & Yu, W. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.09.016 · Cited by 134
Circular RNAs: An emerging type of RNA in cancer
Hou, L., & Zhang, J. (2017) · International Journal of Immunopathology and Pharmacology · doi:10.1177/0394632016686985 · Cited by 126
MiR-138 suppressed nasopharyngeal carcinoma growth and tumorigenesis by targeting the CCND1 oncogene
Liu, X., Lv, X.-B., Wang, X.-P., Sang, Y., Xu, S., Hu, K., Wu, M.-S., Liang, Y., Liu, P., Tang, J., et al. (2012) · Cell Cycle · doi:10.4161/cc.20898 · Cited by 111
Self-citationSun, C., Li, S., & Li, D. (2016) · Oncotarget · doi:10.18632/oncotarget.8482 · Cited by 100
miR‐134 inhibits non‐small cell lung cancer growth by targeting the epidermal growth factor receptor
Qin, Q., Wei, F., Zhang, J., Wang, X.-W., & Li, B. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12889 · Cited by 76
Self-citationLiu, Y., Zhang, M., Qian, J., Bao, M., Meng, X., Zhang, S., Zhang, L., Zhao, R., Li, S., Cao, Q., et al. (2015) · DNA and Cell Biology · doi:10.1089/dna.2014.2629 · Cited by 66
Fang, Y., Gu, X., Li, Z., Xiang, J., & Chen, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2465 · Cited by 63
MicroRNA-490-3p inhibits proliferation of A549 lung cancer cells by targeting CCND1
Gu, H., Yang, T., Fu, S., Chen, X., Guo, L., & Ni, Y. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.020 · Cited by 53
miR-134 suppresses the migration and invasion of non-small cell lung cancer by targeting ITGB1
Qin, Q., Wei, F., Zhang, J., & Li, B. (2017) · Oncology Reports · doi:10.3892/or.2017.5350 · Cited by 49
Lv, S., Xue, J., Wu, C., Wang, L., Wu, J., Xu, S., Liang, X., & Lou, J. (2016) · Journal of Cancer · doi:10.7150/jca.16644 · Cited by 48
Hiroyama, M., & Takenawa, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.29172 · Cited by 46
Zhang, X., Wang, H., Zhang, S., Song, J., Zhang, Y., Wei, X., & Feng, Z. (2012) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-012-9482-3 · Cited by 45
Quantitative assessment of short amplicons in FFPE-derived long-chain RNA
Kong, H., Zhu, M., Cui, F., Wang, S., Gao, X. J., Lu, S., Wu, Y., & Zhu, H. (2014) · Scientific Reports · doi:10.1038/srep07246 · Cited by 31
Deffebach, M. E., & Humphrey, L. L. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.05.006 · Cited by 22
Decreased Expression of MIR-134 and its Clinical Significance in Human Colorectal Cancer.
Xie, Y., Song, J. H., Zong, Q., Wang, A., Yang, Y., Liu, F., & Meng, X.-L. (2015) · PubMed · Cited by 12
Cited by
Circular RNAs in cancer: opportunities and challenges in the field
Kristensen, L. S., Hansen, T. B., Venø, M. T., & Kjems, J. (2018) · Oncogene · doi:10.1038/onc.2017.361 · Cited by 1,326
Circular RNAs function as ceRNAs to regulate and control human cancer progression
Zhong, Y., Du, Y., Yang, X., Mo, Y., Fan, C., Xiong, F., Ren, D., Ye, X., Li, C., Wang, Y., et al. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0827-8 · Cited by 1,007
Circular RNA and its mechanisms in disease: From the bench to the clinic
Han, B., Chao, J., & Yao, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.010 · Cited by 788
Circular RNAs: Promising Biomarkers for Human Diseases
Zhang, Z., Yang, T., & Xiao, J. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.07.036 · Cited by 775
MicroRNAs and complex diseases: from experimental results to computational models
Chen, X., Xie, D., Zhao, Q., & You, Z.-H. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbx130 · Cited by 638
Metadata
- Authors
- Zhu, X., Wang, X., Wei, S., Chen, Y., Chen, Y., Fan, X., Han, S., & Wu, G.
- Venue
- The FEBS Journal
- Publisher
- Wiley
- Published
- 2017-07
- Volume
- 284
- Issue
- 14
- Pages
- 2170-2182
- ISSN
- 1742-464X (ISSN-L)
- 1742-4658
- OpenAlex
- W2726649874
- Cited by
- 295
- References
- 35
- FWCI
- 17.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.